1AD — Adalta Share News
0.000.00%
- AU$9.18m
- AU$7.60m
- AU$0.70m
Australia Stock Exchange release from ADALTA : Notice of Annual General Meeting/Proxy Form
Australia Stock Exchange release from ADALTA : Virtual Meeting Voting and Registration Guide
Australia Stock Exchange release from ADALTA : Jobkeeper s323DB Notice
Australia Stock Exchange release from ADALTA : Change of Director's Interest Notice
Australia Stock Exchange release from ADALTA : Company Presentation - AusBiotech and Bio-Europe
Australia Stock Exchange release from ADALTA : Quarterly Appendix 4C and Activities Report
Australia Stock Exchange release from ADALTA : PRE_NR Ends: 08:35:35
Australia Stock Exchange release from ADALTA : PRE_NR Ends: 08:34:20
Australia Stock Exchange release from ADALTA : BTB funding transferred to AD-214 inhalation program
Australia Stock Exchange release from ADALTA : Notification of Date of 2021 AGM
Australia Stock Exchange release from ADALTA : PRE_NR Ends: 09:31:00
Australia Stock Exchange release from ADALTA : New pre-clinical data presented at Boston conference
Australia Stock Exchange release from ADALTA : Corporate overview and IRD Invest 2021 presentation
Australia Stock Exchange release from ADALTA : PRE_NR Ends: 08:58:22
Brief: Adalta Says Executed A A$4.0 Million Non-Dilutive Funding Facility
Australia Stock Exchange release from ADALTA : PRE_NR Ends: 08:51:04
Australia Stock Exchange release from ADALTA : 4.0M Non-Dilutive Financing with Victorian Government
Australia Stock Exchange release from ADALTA : Preliminary Final Report
Australia Stock Exchange release from ADALTA : Annual Report to shareholders